These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26510914)

  • 21. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
    Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
    Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
    Fujisawa T; Joshi BH; Puri RK
    Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.
    Zhu N; Ware CF; Lai MM
    Virology; 2001 May; 283(2):178-87. PubMed ID: 11336543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis.
    Jin Z; El-Deiry WS
    Mol Cell Biol; 2006 Nov; 26(21):8136-48. PubMed ID: 16940186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
    Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
    Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
    Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
    J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FADD the bad in head and neck cancer.
    Dent P
    Cancer Biol Ther; 2013 Sep; 14(9):780-1. PubMed ID: 23974629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detachment of esophageal carcinoma cells from extracellular matrix causes relocalization of death receptor 5 and apoptosis.
    Liu GC; Zhang J; Liu SG; Gao R; Long ZF; Tao K; Ma YF
    World J Gastroenterol; 2009 Feb; 15(7):836-44. PubMed ID: 19230044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine.
    Schmid D; Fay F; Small DM; Jaworski J; Riley JS; Tegazzini D; Fenning C; Jones DS; Johnston PG; Longley DB; Scott CJ
    Mol Ther; 2014 Dec; 22(12):2083-2092. PubMed ID: 25200008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the Role of the Death Receptor 5/FADD/caspase-8 Death Signaling in Cancer Metastasis.
    Sun SY
    Mol Cell Pharmacol; 2011 Jan; 3(1):31-34. PubMed ID: 21461184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasion and metastasis: stem cells, screens and survival. Conference on Invasion and Metastasis.
    Tapon N; Ziebold U
    EMBO Rep; 2008 Nov; 9(11):1078-83. PubMed ID: 18846106
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of cellular proteases and their inhibitors in invasion and metastasis. Introductionary overview.
    Liotta L
    Cancer Metastasis Rev; 1990 Dec; 9(4):285-7. PubMed ID: 2097082
    [No Abstract]   [Full Text] [Related]  

  • 35. Engineering to find function.
    Doerr A
    Nat Methods; 2013 Aug; 10(8):698. PubMed ID: 24058979
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of targeted interference of Golgi protein 73 gene on invasion and metastasis of liver cancer cells].
    Dilireba B; Yang Y; Huang FL; Liu P; Mao R; Zhang RL; Zhang SA; Xiao L; Bao YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):452-5. PubMed ID: 27465951
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural and molecular aspects of cancer invasion and metastasis.
    Tachikawa T; Mori M
    Med Electron Microsc; 1999 May; 32(1):1. PubMed ID: 11810418
    [No Abstract]   [Full Text] [Related]  

  • 38. Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells.
    Lim SC; Jeon HJ; Kee KH; Lee MJ; Hong R; Han SI
    Int J Oncol; 2016 Nov; 49(5):1983-1990. PubMed ID: 27665736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Niacin alleviates TRAIL-mediated colon cancer cell death via autophagy flux activation.
    Kim SW; Lee JH; Moon JH; Nazim UM; Lee YJ; Seol JW; Hur J; Eo SK; Lee JH; Park SY
    Oncotarget; 2016 Jan; 7(4):4356-68. PubMed ID: 26517672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion.
    Oh YT; Yue P; Sun SY
    Cell Commun Signal; 2017 May; 15(1):18. PubMed ID: 28482915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.